Upregulation of Rpn10 promotes tumor progression via activation of the NF-κB pathway in clear cell renal cell carcinoma

被引:2
作者
Huang, Tingting [1 ]
Tian, Wei [1 ]
Zhou, Qingqing [1 ]
Li, Jiajun [1 ]
Jiang, Zhiyuan [1 ]
Chen, Jinsi [1 ]
Ge, Chao [1 ]
Tian, Hua [1 ]
机构
[1] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai 200032, Peoples R China
基金
上海市自然科学基金; 中国国家自然科学基金;
关键词
Rpn10; prognosis; NE-kappa B; clear cell renal cell carcinoma; HEPATOCELLULAR-CARCINOMA; PROTEASOME; CANCER; MIGRATION;
D O I
10.1093/abbs/gmab078
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The ubiquitin-proteasome system (UPS) plays a central role in regulating protein homeostasis in tumor progression. The proteasome subunit Rpn10 is associated with the progression of several tumor types. However, little is known regarding the role of Rpn10 in clear cell renal cell carcinoma (ccRCC). In this study, we found that overexpression of Rpn10 increased ccRCC cell proliferation, migration, and invasion. Silencing Rpn10 expression resulted in decreased cell proliferation, migration, and invasion in ccRCC cells. Knockdown of Rpn10 inhibits tumor growth and cell proliferation in vivo. Furthermore, we demonstrated that Rpn10 increased cell proliferation, migration, and invasion via regulation of the nuclear factor kappa B (NE-kappa B) pathway. Rpn10 directly promoted inhibitor of nuclear factor-kappa B alpha (I kappa B alpha) degradation through the UPS. Moreover, we observed that upregulation of Rpn10 or downregulation of I kappa B alpha in ccRCC was associated with poor prognosis. We found that the combination of these two parameters was a more powerful predictor of poor prognosis than either parameter alone. Collectively, these findings provide evidence that Rpn10 promotes the progression of ccRCC by regulation of the NE-kappa B pathways and is a prognostic indicator for patients with ccRCC.
引用
收藏
页码:988 / 996
页数:9
相关论文
共 50 条
[41]   RELT promotes the growth of esophageal squamous cell carcinoma by activating the NF-κB pathway [J].
Yao, Wenjian ;
Chen, Qing ;
Li, Saisai ;
Jia, Xiangbo ;
Xu, Lei ;
Wei, Li .
CELL CYCLE, 2021, 20 (13) :1231-1241
[42]   FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway [J].
Jiang, Kun ;
Xu, Li-zhe ;
Ning, Jin-zhuo ;
Cheng, Fan .
CANCER CELL INTERNATIONAL, 2023, 23 (01)
[43]   SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway [J].
He-Xi Wang ;
Zhi-Peng Zhao ;
Xiao-Yi Du ;
Sen-Lin Peng ;
Hao-Yu Xu ;
Wei Tang ;
Lei Yang .
Medical Oncology, 41
[44]   SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway [J].
Wang, He-Xi ;
Zhao, Zhi-Peng ;
Du, Xiao-Yi ;
Peng, Sen-Lin ;
Xu, Hao-Yu ;
Tang, Wei ;
Yang, Lei .
MEDICAL ONCOLOGY, 2024, 41 (02)
[45]   FAP promotes clear cell renal cell carcinoma progression via activating the PI3K/AKT/mTOR signaling pathway [J].
Kun Jiang ;
Li-zhe Xu ;
Jin-zhuo Ning ;
Fan Cheng .
Cancer Cell International, 23
[46]   FN1 Promotes Thyroid Carcinoma Cell Proliferation and Metastasis by Activating the NF-Κb Pathway [J].
Chen, Chen ;
Shen, Zhijun .
PROTEIN AND PEPTIDE LETTERS, 2023, 30 (01) :54-64
[47]   Selenoprotein S regulates tumorigenesis of clear cell renal cell carcinoma through AKT/ GSK3β/NF-κB signaling pathway [J].
Mao, Huajie ;
Zhao, Ya ;
Lei, Li ;
Hu, Yanxia ;
Zhu, Hangrui ;
Wang, Runzhi ;
Ni, Dongsheng ;
Liu, Jianing ;
Xu, Lei ;
Xia, Hua ;
Zhang, Zaikuan ;
Ma, Meng ;
Pan, Zheng ;
Zhou, Qin ;
Xie, Yajun .
GENE, 2022, 832
[48]   HN1 promotes tumor associated lymphangiogenesis and lymph node metastasis via NF-κB signaling activation in cervical carcinoma [J].
Chen, Jueming ;
Qiu, Jiaqi ;
Li, Fengyan ;
Jiang, Xingyu ;
Sun, Xiaoying ;
Zheng, Lie ;
Zhang, Weijing ;
Li, Han ;
Wu, Haiyan ;
Ouyang, Ying ;
Chen, Xiangfu ;
Lin, Chuyong ;
Song, Libing ;
Zhang, Yanna .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2020, 530 (01) :87-94
[49]   DUSP9 Suppresses Proliferation and Migration of Clear Cell Renal Cell Carcinoma via the mTOR Pathway [J].
Luo, Jing ;
Luo, Xing ;
Liu, Xin ;
Fang, Zhenqiang ;
Xu, Jie ;
Li, Longkun .
ONCOTARGETS AND THERAPY, 2020, 13 :1321-1330
[50]   Allicin inhibits human renal clear cell carcinoma progression via suppressing HIF pathway [J].
Song, Bin ;
Shu, Ying ;
Cui, Tianlei ;
Fu, Ping .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11) :20573-20580